Compare SNDX & NOMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNDX | NOMD |
|---|---|---|
| Founded | 2005 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | 2014 | 2015 |
| Metric | SNDX | NOMD |
|---|---|---|
| Price | $22.19 | $10.78 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 5 |
| Target Price | ★ $80.23 | $17.40 |
| AVG Volume (30 Days) | 1.1M | ★ 1.5M |
| Earning Date | 05-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.20% |
| EPS Growth | ★ 11.56 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $172,352,000.00 | N/A |
| Revenue This Year | $619.64 | $3.48 |
| Revenue Next Year | $115.96 | $1.18 |
| P/E Ratio | ★ N/A | $8.38 |
| Revenue Growth | ★ 627.84 | N/A |
| 52 Week Low | $8.59 | $10.67 |
| 52 Week High | $22.73 | $20.81 |
| Indicator | SNDX | NOMD |
|---|---|---|
| Relative Strength Index (RSI) | 61.76 | 25.04 |
| Support Level | $19.59 | N/A |
| Resistance Level | $22.33 | $12.36 |
| Average True Range (ATR) | 1.02 | 0.32 |
| MACD | 0.13 | -0.26 |
| Stochastic Oscillator | 87.03 | 2.28 |
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a selective menin-MLL inhibitor for KMT2A-rearranged (MLL-r) and NPM1-mutant acute leukemias, including ALL and AML. It is also developing axatilimab, a CSF-1R-blocking antibody for cGVHD and idiopathic pulmonary fibrosis. Entinostat is its oral, small molecule product candidate that has direct effects on both cancer cells and immune regulatory cells. The business activity of the group is functioned through the region of the United States.
Nomad Foods Ltd is a packaged foods company that is involved in the business of manufacturing and distribution of branded frozen foods in Western Europe. The company manufactures and markets frozen food products such as fish, vegetables, poultry, Ice Cream and ready meals like pizza. It sells its products through large grocery retailers under the brand Birds Eye in the United Kingdom and Ireland, Findus in Italy, France, Spain, and Scandinavia, and Iglo in Germany and other continental markets. The company operates through a single segment being Frozen. The majority of the revenue is generated from the United Kingdom.